Penicillamine is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Ani Pharmaceuticals, Inc.. The primary component is Penicillamine.
Product ID | 43975-309_637901c4-0796-478b-8bbc-5860f0804f6b |
NDC | 43975-309 |
Product Type | Human Prescription Drug |
Proprietary Name | Penicillamine |
Generic Name | Penicillamine |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2019-05-07 |
Marketing End Date | 2022-06-30 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA209921 |
Labeler Name | ANI Pharmaceuticals, Inc. |
Substance Name | PENICILLAMINE |
Active Ingredient Strength | 250 mg/1 |
Pharm Classes | Antirheumatic Agent [EPC] |
NDC Exclude Flag | N |
Marketing Start Date | 2019-05-07 |
Marketing End Date | 2022-06-30 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA209921 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2019-05-07 |
Ingredient | Strength |
---|---|
PENICILLAMINE | 250 mg/1 |
NDC | Brand Name | Generic Name |
---|---|---|
0254-2000 | penicillamine | penicillamine |
0591-4171 | Penicillamine | Penicillamine |
43598-634 | Penicillamine | Penicillamine |
43975-309 | Penicillamine | Penicillamine |
49884-146 | Penicillamine | penicillamine |
51991-974 | Penicillamine | Penicillamine |
60505-4696 | Penicillamine | Penicillamine |
62559-970 | Penicillamine | Penicillamine |
68475-201 | Penicillamine | Penicillamine |
68682-020 | penicillamine | penicillamine |
70010-907 | Penicillamine | Penicillamine |
70748-153 | Penicillamine | Penicillamine |
71205-916 | Penicillamine | Penicillamine |
25010-705 | Cuprimine | penicillamine |
0378-0709 | D-Penamine | Penicillamine |
0037-4401 | Depen | Penicillamine |